KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Finished Goods (2016 - 2019)

NovoCure's Finished Goods history spans 6 years, with the latest figure at $12.9 million for Q2 2019.

  • For Q2 2019, Finished Goods rose 6.49% year-over-year to $12.9 million; the TTM value through Jun 2019 reached $12.9 million, up 6.49%, while the annual FY2018 figure was $13.0 million, 39.77% up from the prior year.
  • Finished Goods for Q2 2019 was $12.9 million at NovoCure, down from $14.4 million in the prior quarter.
  • Across five years, Finished Goods topped out at $14.4 million in Q1 2019 and bottomed at $4.9 million in Q3 2015.
  • The 5-year median for Finished Goods is $10.9 million (2017), against an average of $10.3 million.
  • The largest annual shift saw Finished Goods surged 232.8% in 2015 before it plummeted 32.63% in 2017.
  • A 5-year view of Finished Goods shows it stood at $5.5 million in 2015, then soared by 120.12% to $12.0 million in 2016, then fell by 22.47% to $9.3 million in 2017, then skyrocketed by 39.77% to $13.0 million in 2018, then fell by 0.85% to $12.9 million in 2019.
  • Per Business Quant, the three most recent readings for NVCR's Finished Goods are $12.9 million (Q2 2019), $14.4 million (Q1 2019), and $13.0 million (Q4 2018).